Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Fitoterapia|December 26, 2012
Fucoidan prevents multiple myeloma cell escape from chemotherapy-induced drug cytotoxicityJinglong Lv, Qing Xiao, Li Wang, et al.
American Journal of Cancer Research|April 20, 2026
THAP7-AS1 orchestrates IGF2BP3-m<sup>6</sup>A-dependent CCN2 mRNA stabilization to promote lymphatic metastasis in bladder cancerQiuyan Li, Junjie Bai, Shiwen Zheng, et al.
Oncology Reports|July 14, 2015
SPARC ectopic overexpression inhibits growth and promotes programmed cell death in acute myeloid leukemia transformed from myelodysplastic syndrome cells, alone and in combination with Ara-C treatmentQing Nian, Jianxiang Chi, Qing Xiao, et al.
Contrast Media & Molecular Imaging|May 26, 2022
Applicability of 14 Formulas for Estimating Glomerular Filtration Rate in the Evaluation of Renal Function before and after Nephron-Sparing Surgery in Patients with Renal TumorsQiuyan Li, ZeSong Yang, Shiwen Zheng, et al.
International Journal of Medical Sciences|November 11, 2020
Modified three-level techniques of retroperitoneal laparoscopic procedures to treat adrenal lesions for patients with BMI ≥ 25 Kg/m<sup>2</sup>Minxiong Hu, Zesong Yang, Yuandong Chen, et al.
Scientific Reports|March 23, 2022
The effect of preoperative urine culture and bacterial species on infection after percutaneous nephrolithotomy for patients with upper urinary tract stonesZesong Yang, Ding Lin, Yun Hong, et al.
Cell Communication and Signaling : CCS|June 7, 2024
The FABD domain is critical for the oncogenicity of BCR/ABL in chronic myeloid leukaemiaRenren Zheng, Wei Wei, Suotian Liu, et al.
Frontiers in Endocrinology|March 19, 2024
Modified versus three-level technique of retroperitoneal laparoscopic adrenalectomy for all patients with adrenal lesions ≤ 6cm: a retrospective, case-controlled studyMinxiong Hu, Yangbiao Wu, Xiao Xu, et al.
Cancer Biology & Therapy|November 30, 2023
Clinical significance of WT1 in the evaluation of therapeutic effect and prognosis of non-M3 acute myeloid leukemiaTingyu Yu, Qian Zhan, Xinyu Yan, et al.
Endocrine|July 11, 2016
In vitro and in vivo inhibition of mTOR by 1,25-dihydroxyvitamin D<sub>3</sub> to improve early diabetic nephropathy via the DDIT4/TSC2/mTOR pathwayHang Wang, Jianmin Wang, Hua Qu, et al.
Pageof 6